论文部分内容阅读
Patients with thoracic malignancies invading thesuperior vena cava(SVC)and innominate vein thatcause venous flow obstruction have a p loor quality of lifeand short survival time.Dartevelle et al reported that the3-year survival rates were 27% for patients withmediastinal malignancies and non-small cell lung cancer.Recently,some surgeons’ experience suggested that theresults of extensive resection and reconstruction of theSVC and innominate vein were excellent.From May2003 to December 2005,radical resection andreconstruction of the SVC and/or innominate vein wereperformed in a group of patients for mediastinal or lungtumors invading the superior vena cava and/orinnominate vein.We reported our experience in thisretrospective study to explore the operative method,theoptimal vascular graft,and the benefits of extendedresection and reconstruction of SVC and/or innominatevein for invasive thoracic tumors.
Patients with thoracic malignancies invading thesuperior vena cava (SVC) and innominate vein thatcause venous flow obstruction have ap loor quality of life and short survival time. Hearte et al reported that the 3-year survival rates were 27% for patients withmediastinal malignancies and non-small cells lung cancer. Recently, some surgeons’ experience suggested that the results of extensive resection and reconstruction of the SVC and innominate vein were excellent. Motion May 2003 to December 2005, radical resection and reconstruction of the SVC and / or innominate vein were performed in a group of patients for mediastinal or lungtumors invading the superior vena cava and / orinnominate vein. We reported our experience in thisretrospective study to explore the operative method, theoptimal vascular graft, and the benefits of extendedresection and reconstruction of SVC and / or innominatevein for invasive thoracic tumors.